This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking reagents. The contract was awarded by the Defense Logistics Agency (DLA) and has a ceiling value of $17,441.00. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the supply of ALBACLONE Anti-P1 medical products, which are likely critical blood banking supplies supporting diagnostic testing, blood typing, and...
This federal contract award, valued at $2,370.00, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking reagents. The award is a Delivery Order contract for the supply of ALBACLONE Anti-A products. This contract is not set aside for any specific type of small business. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc. and has a history of providing specialized medical...
This contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order for $14,457.00 with Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract is for the delivery of ALBACLONE Anti-A products and has a completion date of September 5, 2024. This contract is not designated as a set-aside. Alba...
This federal contract award was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The $1,118.00 Firm Fixed Price Delivery Order (SPE2DE22D0008|SPE2D625F38A1) is for the product "ALBACLONE ANTI-A" and has an ultimate completion date of December...
This federal contract award was made by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $2,370.00, is for the delivery of ALBACLONE anti-B products. The award is not associated with a set-aside program and is a Firm Fixed Price Delivery Order contract type. Alba...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various federal agencies. The contract, valued at $10,500.00, is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is being awarded by the Defense Logistics Agency (DLA) Medical Supply Chain and is for the supply of ALBACLONE Anti-C (Big C) reagents. The...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking supplies. The contract, valued at $4,582.00, is a Delivery Order contract with a Firm Fixed Price pricing type, awarded by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the provision of ALBACYTE Antibody ID Panels, which are specialized blood banking products used for diagnostic testing, blood typing, and transfusion...
This federal contract award, with ID SPE2DE22D0008|SPE2D625F1414, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The contract, with a ceiling value of $1,118.00, is for the delivery of "ALBACLONE ANTI-A" products, which are likely blood typing reagents or antibodies used in blood banking operations. The contract is a Delivery...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned for-profit organization, for the provision of ALBACLONE ANTI-A medical supplies. The contract has a ceiling value of $1,123.00 and a period of performance through April 4, 2024. It is a firm fixed price contract, and there was no set-aside designation used. Alba Bioscience, Inc. is a leading provider of specialized in vitro diagnostics and blood bank reagents, and this...
This federal contract award was made by the Medical Supply Chain, a defense agency, to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking supplies. The $1,560.00 firm fixed price delivery order is for ALBACLONE anti-LEA products, with a completion date of May 19, 2025. Alba Bioscience, Inc. holds several significant federal Indefinite Delivery Vehicles (IDVs), including Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs...